about
Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer.Protein kinase A type II-α regulatory subunit regulates the response of prostate cancer cells to taxane treatment.USP7 and Daxx regulate mitosis progression and taxane sensitivity by affecting stability of Aurora-A kinaseMicrotubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The microtubule as a breast cancer target.
@en
The microtubule as a breast cancer target.
@nl
type
label
The microtubule as a breast cancer target.
@en
The microtubule as a breast cancer target.
@nl
prefLabel
The microtubule as a breast cancer target.
@en
The microtubule as a breast cancer target.
@nl
P2860
P1433
P1476
The microtubule as a breast cancer target.
@en
P2093
Gerald M Higa
P2860
P2888
P304
P356
10.1007/S12282-010-0224-7
P577
2010-09-23T00:00:00Z